Arrowhead Pharmaceuticals specializes in genetic treatment of diseases. They develop medicines that treat intractable diseases by silencing the genes that cause them.

Their new 13-acre  Verona campus will consist of two buildings: building 1A which is 142,000 square feet of half laboratory space and half office space, and building 1B which is 146,000 square feet of a cGMP laboratory. Westphal & Company was selected due to our past work with Arrowhead facilities and other pharmaceutical cGMP facilities, both laboratory and manufacturing. 

The Arrowhead campus in Verona is a greenfield site. Westphal was tasked with providing a campus-wide medium voltage distribution system and full campus power backup via (2) 2.5MW and (1) 2MW generators. Westphal will also be a design-build partner on Building 1A responsible for the design of normal and life safety branch power, lighting, lighting control, site and parking lot lighting for the entire campus, and fire alarm system including a smoke evacuation system.

This multi-phased project consist of new labs with clean rooms and process for the use in developing vaccines for animals of the fowl, swine and cattle families in this 55,000 square foot facility in Verona, WI. This phased project is being completed to allow the facility to continue to produce these vaccines insuring the power to freezers and test equipment stayed active during construction. There are plans to expand this facility in to green space adjacent to the current facility. The initial design was completed by GBA Architects of Lenexa, KS and Westphal assisted in making available power and control for the equipment coming from other plants.

Anticipated completion of the renovated area is December 2021.